National Institutes of Health

Description

The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting robust, well-designed, and well-executed clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between NIDCD project collaborator and investigator for a planning grant for phase III clinical trials of definitive efficacy. NIDCD Phase III Clinical Trials in Communication Disorders (U01) applications are accepted only from successful NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) awardees, unless NIDCD program staff agrees to accept a phase III clinical trial application from an investigator who has not used an NIDCD clinical trial planning grant first. The NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) is used to gather information and prepare a Manual of Procedures (MOP) (see http://www.nidcd.nih.gov/research/clinicaltrials for an example of a complete, detailed MOP). NIDCD Phase III Clinical Trials in Communication Disorders (U01) (PAR-12-123) applications must include a complete detailed MOP in the appendix.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV